ATE237347T1 - Behandlung autoimmunerkrankungen in säugern - Google Patents

Behandlung autoimmunerkrankungen in säugern

Info

Publication number
ATE237347T1
ATE237347T1 AT00931296T AT00931296T ATE237347T1 AT E237347 T1 ATE237347 T1 AT E237347T1 AT 00931296 T AT00931296 T AT 00931296T AT 00931296 T AT00931296 T AT 00931296T AT E237347 T1 ATE237347 T1 AT E237347T1
Authority
AT
Austria
Prior art keywords
mammals
treatment
autoimmune diseases
interleukin
composition
Prior art date
Application number
AT00931296T
Other languages
English (en)
Inventor
Gomariz Rosa Perez
Martinez Javier Leceta
Mora Mario Delgado
Mora Carmen Martinez
Original Assignee
Univ Madrid Complutense
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from ES9901235A external-priority patent/ES2160495B1/es
Application filed by Univ Madrid Complutense filed Critical Univ Madrid Complutense
Application granted granted Critical
Publication of ATE237347T1 publication Critical patent/ATE237347T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/2278—Vasoactive intestinal peptide [VIP]; Related peptides (e.g. Exendin)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Vascular Medicine (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT00931296T 1999-06-04 2000-06-02 Behandlung autoimmunerkrankungen in säugern ATE237347T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES9901235A ES2160495B1 (es) 1998-04-17 1999-06-04 Uso de los peptidos vip y pacap para el tratamiento de enfermedades inflamatorias y autoinmunes en mamiferos.
PCT/ES2000/000197 WO2000074708A1 (es) 1999-06-04 2000-06-02 Metodo para el tratamiento del shock entotoxico y enfermedades inflamatorias y autoinmunes en mamiferos

Publications (1)

Publication Number Publication Date
ATE237347T1 true ATE237347T1 (de) 2003-05-15

Family

ID=8308713

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00931296T ATE237347T1 (de) 1999-06-04 2000-06-02 Behandlung autoimmunerkrankungen in säugern

Country Status (7)

Country Link
EP (1) EP1103270B1 (de)
AT (1) ATE237347T1 (de)
AU (1) AU4927700A (de)
CA (1) CA2345030A1 (de)
DE (1) DE60002143T2 (de)
PT (1) PT1103270E (de)
WO (1) WO2000074708A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE502004009530D1 (de) 2003-07-14 2009-07-09 Mondobiotech Ag Substanzen mit biologischer aktivität des vasoaktiven intestinalen peptids für die behandlung von interstitiellen lungenerkrankungen
SI1719773T1 (sl) 2004-02-24 2009-08-31 Japan Tobacco Inc Kondenzirane heterotetraciklične spojine in njihova uporaba kot inhibitorji polimeraze HCV

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2138561B1 (es) * 1998-04-17 2000-07-01 Univ Madrid Complutense Uso de los peptidos vip y pacap en el tratamiento del shock endotoxico en mamiferos.

Also Published As

Publication number Publication date
WO2000074708A1 (es) 2000-12-14
EP1103270B1 (de) 2003-04-16
DE60002143D1 (de) 2003-05-22
DE60002143T2 (de) 2004-03-18
AU4927700A (en) 2000-12-28
CA2345030A1 (en) 2000-12-14
PT1103270E (pt) 2003-08-29
EP1103270A1 (de) 2001-05-30

Similar Documents

Publication Publication Date Title
IL267381A (en) A pharmaceutical preparation containing dextromethorphan and quinidine for the treatment of nervous disorders
PT804252E (pt) Agentes queladores metalicos que contem monoaminas diamidas e tiois
EA200100872A1 (ru) Композиция валдекоксиба
EA200500169A1 (ru) Замещенные производные 1,3-дифенилпроп-2-ен-1-она, получение и применение
DK0682664T3 (da) Forbindelser med både potent calciumantagonist og antioxiderende aktivitet og anvendelse deraf som cytobeskyttende midler
CY1108610T1 (el) Πεπτιδια της il-2 και παραγωγα αυτων και χρηση αυτων ως θεραπευτικοι παραγοντες
CY2607B2 (en) Synergistic combination of pde inhibitors and adenylate cyclase agonists or guanylcyclyse agonists
DE69719798D1 (de) Periphäre verabreichung von glp-1 analogen und derivate zur reguleirung der fettleibigkeit
EA200300171A1 (ru) Циклопентаноиндолы, композиции, содержащие данные соединения, и способы лечения
DE60219887D1 (de) N-(3,-Dimethylindolin-6-yl)ä2-ä(4-pyridylmethyl)aminoü(3-pyridyl)ücarbonsäureamid und dieses enthaltende pharmazeutische Zubereitungen.
EA200200208A1 (ru) Синергитическая композиция
EA200000911A1 (ru) Новые кристаллические формы антивирусного соединения бензимидазола
DK1039912T3 (da) Angiostatiske midler og præparater til behandling af GLC1A-glaukom
EA200500244A1 (ru) Тетрапропиламмония тетратиомолибдат и родственные соединения для антиангиогенной терапии
SV2002000235A (es) Composiciones farmaceuticas que comprenden valdecoxib
DK1032556T3 (da) Farmaceutisk aktive forbindelser og anvendelsesfremgangsmåder
DK0489877T3 (da) Antiatherosklerotiske og antithrombotiske 2-amino-6-phenyl-4H-pyran-4-oner
DE60129829D1 (de) Zyklisierte benzamid-neurokinin-antagonisten zur verwendung in therapie
WO2000078795A3 (en) Rufomycins and derivatives thereof useful as inhibitors of multi-drug resistance associated protein-1 (mrp-1)
ATE237347T1 (de) Behandlung autoimmunerkrankungen in säugern
NO961423D0 (no) Oligopeptider avledet fra C-reaktive proteinfragmenter
MXPA05004121A (es) Metodos para tratar la enfermedad de ojo reseco con lantibioticos.
ATE482217T1 (de) Dithiolopyrrolon-derivate zur behandlung von proliferativen störungen
BR0013665A (pt) Uso de uma proteìna histacalina, composição farmacêutica, e, método de tratar ou impedir conjuntivite
PT1207899E (pt) Tratamento da rinite alergica com certas proteinas de ligacao de aminas vasoactivas

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1103270

Country of ref document: EP

REN Ceased due to non-payment of the annual fee